ES2054843T3 - Compuesto organomineral de vanadilo, procedimiento para obtener tal compuesto, composicion farmaceutica que contiene dicho compuesto organomineral. - Google Patents

Compuesto organomineral de vanadilo, procedimiento para obtener tal compuesto, composicion farmaceutica que contiene dicho compuesto organomineral.

Info

Publication number
ES2054843T3
ES2054843T3 ES88402084T ES88402084T ES2054843T3 ES 2054843 T3 ES2054843 T3 ES 2054843T3 ES 88402084 T ES88402084 T ES 88402084T ES 88402084 T ES88402084 T ES 88402084T ES 2054843 T3 ES2054843 T3 ES 2054843T3
Authority
ES
Spain
Prior art keywords
compound
organomineral
vanadilo
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88402084T
Other languages
English (en)
Spanish (es)
Inventor
Rene Lazaro
Gerard Cros
John H Mcneill
Jean-Jacques Serrano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panmedica SA
Original Assignee
Panmedica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panmedica SA filed Critical Panmedica SA
Application granted granted Critical
Publication of ES2054843T3 publication Critical patent/ES2054843T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/005—Compounds of elements of Group 5 of the Periodic Table without metal-carbon linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES88402084T 1987-08-11 1988-08-10 Compuesto organomineral de vanadilo, procedimiento para obtener tal compuesto, composicion farmaceutica que contiene dicho compuesto organomineral. Expired - Lifetime ES2054843T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711425A FR2619382B1 (fr) 1987-08-11 1987-08-11 Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral

Publications (1)

Publication Number Publication Date
ES2054843T3 true ES2054843T3 (es) 1994-08-16

Family

ID=9354103

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88402084T Expired - Lifetime ES2054843T3 (es) 1987-08-11 1988-08-10 Compuesto organomineral de vanadilo, procedimiento para obtener tal compuesto, composicion farmaceutica que contiene dicho compuesto organomineral.

Country Status (10)

Country Link
US (1) US5023358A (en:Method)
EP (1) EP0305264B1 (en:Method)
JP (1) JPS6466159A (en:Method)
KR (1) KR890003784A (en:Method)
AT (1) ATE86258T1 (en:Method)
CA (1) CA1315476C (en:Method)
DE (1) DE3878790T2 (en:Method)
ES (1) ES2054843T3 (en:Method)
FR (1) FR2619382B1 (en:Method)
GR (1) GR3007484T3 (en:Method)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175001A (en) * 1987-08-11 1992-12-29 Panmedica, S.A. Vanadyl organo-mineral compound, method for obtaining such a compound, pharmaceutical composition containing this organo-mineral compound
FR2666182B1 (fr) * 1990-08-27 1992-10-16 Alcatel Telspace Demodulateur hyperfrequence pour liaisons hertziennes numeriques utilisant une modulation de type maq.
US5164384A (en) * 1991-06-19 1992-11-17 Metagenics, Inc. Anabolic mineral formula
FR2678622B1 (fr) * 1991-07-03 1994-11-18 Adir Nouveaux complexes de vanadium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5300496A (en) * 1991-09-30 1994-04-05 The University Of British Columbia Complexed vanadium for the treatment of diabetes mellitus
US5527790A (en) * 1991-09-30 1996-06-18 The University Of British Columbia Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar
US5866563A (en) * 1991-09-30 1999-02-02 The University Of British Columbia Vanadium compositions
IL99666A (en) * 1991-10-07 1996-09-12 Yeda Res & Dev Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them
FR2686511B1 (fr) * 1992-01-28 1995-06-23 Ir2M Composition pharmaceutique contenant des associations de vanadium et/ou de niobium avec des acides amines ou des derives d'acides amines.
FR2686600B1 (fr) * 1992-01-28 1995-07-13 Ir2M Complexes organometalliques de l'inositol et de ses derives, leur preparation et composition pharmaceutique contenant ces complexes ou leurs composants.
US5422125A (en) * 1993-07-12 1995-06-06 Baker Norton Pharmaceuticals, Inc. Method and composition for treatment of insulin resistance syndromes
US5843481A (en) * 1994-01-18 1998-12-01 Mount Sinai Hospital Corporation Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
AU6459996A (en) * 1995-07-10 1997-02-10 Enrique G. Gutierrez Composition and method for treating diabetes
US5885980A (en) * 1996-06-25 1999-03-23 Enrique G. Gutierrez Composition and method for treating diabetes
US6232340B1 (en) 1997-04-24 2001-05-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
IL121748A0 (en) * 1997-09-11 1998-02-22 Yeda Res & Dev Vanadium complexes of hydroxamates and pharmaceutical compositions comprising them
RU2190618C2 (ru) * 1999-03-10 2002-10-10 Казанский государственный университет им. В.И.Ульянова-Ленина Новое комплексное соединение оксованадия (iv) с гидразидом изоникотиновой кислоты, обладающее антидиабетическим действием и проявляющее антимикобактериальную активность
GR1004470B (el) * 2000-07-07 2004-03-04 Help Ανωνυμη Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Και Νοσοκομειακων Ειδων Μεθοδοι συνθεσης συμπλοκων ενωσεων του βαναδιου (ιιι) με τις σουλφυδρυλικες ενωσεις (-sh, θειολες) κυστεινη (h2cys) και n-(μερκαπτοπροπιονυλ)- γλυκινη για την παρασκευη σκευασματων προοριζομενων για τη θεραπεια του σακχαρωδη διαβητη και των κακοηθων νοσηματων στον ανθρωπο

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076830A (en) * 1959-04-29 1963-02-05 Merck & Co Inc Vanadium compounds

Also Published As

Publication number Publication date
GR3007484T3 (en:Method) 1993-07-30
DE3878790T2 (de) 1993-06-09
KR890003784A (ko) 1989-04-18
FR2619382B1 (fr) 1990-05-04
JPS6466159A (en) 1989-03-13
EP0305264B1 (fr) 1993-03-03
FR2619382A1 (fr) 1989-02-17
EP0305264A1 (fr) 1989-03-01
US5023358A (en) 1991-06-11
CA1315476C (en) 1993-03-30
DE3878790D1 (de) 1993-04-08
ATE86258T1 (de) 1993-03-15

Similar Documents

Publication Publication Date Title
ES2054843T3 (es) Compuesto organomineral de vanadilo, procedimiento para obtener tal compuesto, composicion farmaceutica que contiene dicho compuesto organomineral.
IL90912A0 (en) Condensed heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
ATE75142T1 (de) Dhp-manteltablette.
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
SE8300736D0 (sv) Novel pharmacologically active compounds
BR9307451A (pt) Composto, composição farmacêutica e processo para fabricação de composto
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
GR3001889T3 (en) Prodrug compounds, process for the preparation thereof and sustained release preparation comprising the same
EP0358284A3 (en) Derivatized alkanolamines as cardiovascular agents
NO153397C (no) Analogifremgangsmaate ved fremstilling av stabile s-adenosylmethioninestere.
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
IL66960A0 (en) 4-phenyl-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
DE59004292D1 (de) Renin-hemmende Aminooligohydroxy-Derivate.
PT91873A (pt) Processo para a preparacao de composicoes farmaceuticas contendo acidos oxapenem-3-carboxilicos estaveis uteis como inibidores de beta-lactamase
IL86169A0 (en) Substituted quinoxalyl-imidazolidine-2,4-diones,processes for their preparation and pharmaceutical compositions containing them
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
KR950000701A (ko) 로라카베프 이수화물을 로라카베프 일수화물로 전환시키는 방법
IL60383A0 (en) Cyclophosphathiazene derivatives,their preparation and pharmaceutical compositions containing them
BR8206677A (pt) Processo para a preparacao de alquilcicloalquil-imidazolil-meril-cetonas e aplicacao
DK151689A (da) Tc-99m-praeparat til knoglescintigrafi, dets fremstilling og anvendelse
SE7907656L (sv) 3,4-dihydroxikanelaldehydderivat
SE8302976L (sv) Farmaceutiska kompositioner innehallande minst en polyflourerad alkohol
KR900014372A (ko) 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제
JPS5283349A (en) Synthesis of novel 4-substitutedamido-3,5-dihalogeno-alpha-substituted-ami nomethylbenzylalcohols

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 305264

Country of ref document: ES